Date of Award
Spring 3-14-2025
Embargo Period
3-14-2026
Document Type
Dissertation - MUSC Only
Degree Name
Doctor of Health Administration
College
College of Health Professions
First Advisor
Daniel Brinton
Second Advisor
Jillian Harvey
Third Advisor
Kesley Holmes
Abstract
Retention in Alzheimer’s disease clinical trials is a critical challenge, with participant withdrawal impacting statistical power, data integrity, and generalizability. Underrepresented racial and ethnic groups (URGs) face disproportionately high dropout rates, necessitating a deeper understanding of withdrawal predictors. This retrospective cohort study analyzed demographic and site-related factors influencing withdrawal in ADNI1, ADNI2, and ADNI-GO trials using publicly available data from the Laboratory of Neuro Imaging (LONI) database. After data cleaning, the final dataset included 3,008 participants, with 1,324 withdrawn and 1,684 retained. Logistic regression identified younger age (p < .001, OR = 0.977), retired status (p = .005, OR = 1.309), race (p = .003, OR = 0.784), and site number (p < .001, OR = 1.004) as significant predictors of withdrawal, while gender, marital status, handedness, primary language, and education level were non-significant. These findings suggest that targeted retention strategies for younger and retired participants, culturally tailored engagement for URGs, and site-specific monitoring could improve retention and enhance the diversity and generalizability of Alzheimer’s disease research.
Recommended Citation
Alkatib, Kallie, "Predictors of Early Withdrawal in Alzheimer's Disease Clinical Trials: The Role of Demographics in Retention" (2025). MUSC Theses and Dissertations. 1037.
https://medica-musc.researchcommons.org/theses/1037
Rights
Copyright is held by the author. All rights reserved.